$2.7 Billion European Cardiac Surgery Market Expected to Grow 67% by 2024 Due to TAVI and TMVr Adoption – New Study by iData Research

TAVI remains the largest revenue generator among transcatheter heart valve therapies, accounting for nearly 50% of the total cardiac surgery device market.